USANA HEALTH SCIENCES INC 8-K/A

What Happened
USANA Health Sciences, Inc. (USNA) filed an 8-K on Feb. 11, 2026 reporting that Jim Brown stepped down as the company’s Chief Executive Officer and President and that Kevin Guest, the Company’s Chairman of the Board, reassumed the role of Chief Executive Officer. The filing states the Compensation Committee has now determined compensation arrangements for Mr. Brown and Mr. Guest and includes a Transition Agreement effective February 5, 2026.

Key Details

• Jim Brown stepped down as CEO and President; Kevin Guest reassumed CEO duties (filing dated Feb. 11, 2026).
• Transition Agreement between USANA and Jim Brown is attached as Exhibit 10.1 and is effective February 5, 2026.
• The Compensation Committee has determined compensation arrangements for both Mr. Brown and Mr. Guest (details were not disclosed in the 8-K text).
• The report was signed by G. Douglas Hekking, Chief Financial Officer.

Why It Matters
Leadership changes at the CEO level are material for investors because they can affect company strategy, execution, and market confidence. The filing confirms a formal transition and that executive compensation decisions have been made, but it does not disclose financial terms in this 8-K; investors should watch for future filings or disclosures that provide the compensation details and any operational or strategic guidance tied to the leadership change.